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July 26, 2011:548–51account for the increase in both VF and acute HF risk in patients
presenting with STE in lead V4R. The interventricular septum is
nown to play an important role in arrhythmias after myocardial
nfarction (1). Morita et al. (2) demonstrated that acute ischemia
f the interventricular septum in canine cardiac wedge preparations
roduced asymmetric suppression of conduction velocity in the
eptum, and they suggested that such changes could contribute to
he initiation of arrhythmia in patients with septal infarction.
ore recently, Sicouri et al. (3) demonstrated that dispersion of
epolarization across the interventricular septum in canine wedge
reparations is twice that of the left ventricular free wall, predis-
osing to development of Torsades de Pointes arrhythmias. The
elatively low incidence of the combined end point (primary VF,
cute HF, or both) calls for caution in the interpretation of the
esults, especially with regard to the multivariate analysis. Should
ur findings be confirmed in a larger cohort, we would recommend
hat right precordial leads be a routine part of the initial electro-
ardiographic study in all patients with anterior STEMI.
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Risk Associated With ST-Segment Elevation in the RightTable 1 Risk Associated With ST-Segment Elevatio
Variable
Crude Event R
(Right vs. Nonright
Primary VF, acute HF, or death 54% vs. 18%
Acute HF 39% vs. 17%
Primary VF 21% vs. 3%
*Adjusted for age, sex, left ventricular ejection fraction, the sum
multivariate analysis for VF cannot be reported because of the small
HF  heart failure; STEMI  ST-segment elevation myocardial infarlan Goldenberg, MD
interval 366 ms at 66 beats/min). The electrocardiogram appears toAmir Sandach, PhD
Roy Beigel, MD
Michael Glikson, MD
Micha S. Feinberg, MD
Michael Eldar, MD
*Shlomi Matetzky, MD
*Leviev Heart Center
Sheba Medical Center
Tel Hashomer 52621
Israel
E-mail: shlomi.matetzky@sheba.health.gov.il
doi:10.1016/j.jacc.2011.03.035
EFERENCES
1. Kawamura Y, Page PL, Cardinal R, et al. Mapping of septal ventricular
tachycardia: clinical and experimental correlations. J Thorac Cardiovasc
Surg 1996;112:914–25.
2. Morita ST, Morita H, Zipes DP, et al. Acute ischemia of canine
interventricular septum produces asymmetric suppression of conduc-
tion. Heart Rhythm 2008;5:1057–62.
3. Sicouri S, Glass A, Ferreiro M, et al. Transseptal dispersion of
repolarization and its role in the development of Torsade de Pointes
rdial Leads by Multivariate Analysise Right Precordial Leads by Multivariate Analysis
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for Short QT Syndrome
Are Badly Founded
I would like to commend Gollob et al. (1) for their attempt to
generate criteria on how to diagnose short-QT syndrome (SQTS),
but I would also like to point out some of the shortfalls and errors in
their report.
In Table 1 of their report, at least 1 patient appears to have been
included twice (Patients #23 and #49) with different ages and different
QT intervals. Patient #46, published in 2008, was a 22-year-old man
who “experienced unheralded syncope for the first time while driving,
resulting in a motor vehicle accident” which in the current report is
categorized as aborted cardiac arrest. This patient had no documented
arrhythmias and no short QT interval on electrocardiography (QTdisplay early repolarization, and genetic testing discovered a novel
KCNH2 mutation of undetermined significance, which was also
present in the patient’s mother, who also had a normal QT interval.
This patient does not fit the general concept of a patient with SQTS.
Patients #59 to #61, from a letter to the editor, are also outliers and
should not have been included. These patients had a C-terminal
KCNH2 mutation (R1135H) shown (2) to cause both a short QT
interval and a Brugada-type electrocardiographic pattern, as seen in
Patient #59.
The exclusion of Patients #59 to #61 would have changed Table 2
in their report. Instead of an upper value for the range of QT intervals
in patients with SQTS of 401 ms, the actual value would have been
334 ms.
Using the QT interval corrected by Bazett’s formula in the
proposed diagnostic criteria has important limitations. As already
observed in the very first patient diagnosed with SQTS (3), the QT
interval in SQTS changes very little with changes in heart rate, andPrecon in th
ate
STEM
of ST-scorrection of the QT interval is therefore barely necessary at normal
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July 26, 2011:548–51heart rates. Bazett’s formula will greatly overcorrect the QT interval at
any heart rate60 beats/min, and attempts should always be made to
record an electrocardiogram as close to 60 beats/min as possible by
obtaining data from Holter monitoring or using a beta-blocker.
There is no doubt about the potential arrhythmic risk of a short
QT interval, but corrected QT intervals as low as 340 to 350 ms
(considered normal by some) have been observed for years without
reports of any increased risk for sudden cardiac death. So far, SQTS
has been an extremely rare diagnosis, with no documentation of
sudden cardiac death or aborted sudden cardiac death due to SQTS
when the QT interval is 315 ms.
Therefore, it is my opinion that the proposed diagnostic criteria for
SQTS are poorly founded and should be used with great caution.
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Reply
Dr. Bjerregaard challenges the inclusion of 5 of 61 patients used in
our analysis of reported cases of short-QT syndrome (SQTS) (1). We
commend him on the considerable amount of time spent reviewing
these cases and focusing on the relevance of their inclusion. Dr.
Bjerregaard suggests that cases 23 and 49 are the same patient and
that we have reported the patient twice but with “different ages and
QT intervals.” His rationale for arriving at this conclusion is unclear.
These patients are reported from different published reports, without
any indication of having been previously described, and their differing
QT intervals reflect the values quoted directly from these reports.
With regard to patient #46, Dr. Bjerregaard is concerned about the
terminology used in describing this patient’s clinical event and the fact
that his mother carries the same KCNH2 gene mutation (E50D)
despite having a normal corrected (QTc) interval. This patient (QTc
intervals ranging from 349 to 381 ms) had a sudden loss of conscious-
ness in the absence of a prodrome, resulting in a motor vehicle
accident. After cardiac evaluation, clinically his event was attributed to
a sudden arrhythmia with spontaneous reversion, consistent with the
concept of an aborted cardiac arrest. Dr. Bjerregaard’s concern
regarding a gene carrier demonstrating a normal phenotype is quite
surprising, as this is a common observation in virtually all inherited
arrhythmia conditions. The E50D mutation has never previously
been observed and was absent from the screening of more than 2,600
chromosomes analyzed in a healthy control cohort (2). In collabora-
ion with Dr. Charles Antzelevitch, biophysical analysis of this
utation confirmed a significant gain of function consistent with
revious mutations reported in patients with SQTS.The remaining 3 patients (patients #59 to #61) of concern to Dr.
jerregaard were reported to have a novel KCNH2 gene mutation
R1135H). Biophysical studies demonstrated a significant gain of
unction of the mutant protein consistent with the SQTS phenotype
n these 3 patients (3). One of these patients was also reported to have
“Brugada-type” electrocardiographic (ECG) pattern, although the
2-lead electrocardiogram was not published. Our view is that it is
xtremely unlikely that this patient had a type 1 Brugada ECG
attern, required to conclude a Brugada phenotype, and that the
bserved Brugada-type ECG pattern more likely reflected the non-
pecific type 2 or 3 pattern. The KCNH2 gene, which has been the
ubject of analysis in inherited arrhythmias for more than 15 years, has
ever been associated with a type 1 Brugada ECG pattern.
More relevant to the challenge of diagnosing the SQTS is the issue
f QTc ranges that may be associated with the condition. Dr.
jerregaard suggests that QT interval correction should be avoided
nd that instead, analysis of the absolute QT interval should be
estricted to periods when the heart rate approximates 60 beats/min,
nd he suggests that Holter monitoring would be useful. We do not
elieve that this approach is feasible in clinical practice and do not
dvocate using Holter monitors for the evaluation of QT intervals. All
urrently reported SQTS cases have reported the QTc interval, and
lthough the use of the Bazett correction formula has certain limita-
ions, these limitations are minimized when appropriate reference
anges of “normal” are considered. As described in our report,
umerous large epidemiologic studies have reported the QTc interval
ange in thousands of subjects, providing a useful resource of the
ormal distribution of QTc intervals on resting 12-lead electrocardi-
graphy in the general population.
Last, Dr. Bjerregaard emphasizes that QTc intervals “as low as 340
o 350 ms. . .have been observed for years without reports of any
ncreased risk for sudden cardiac death.” This comment is rather
aive, as the majority of patients with long-QT syndrome and QTc
ntervals in excess of 480 ms diagnosed later in life have led
symptomatic and prosperous lives. This does not reflect the fact that
significant proportion of patients with long-QT syndrome with
imilar QTc intervals have succumbed to the tragedy of a premature
udden death. In addition, we would reiterate that a diagnosis of
QTS using the diagnostic criteria cannot be made based on a QTc
nterval in isolation and requires the inclusion of relevant clinical and
enetic information.
Despite the negative perspective offered by Dr. Bjerregaard, we
elieve that our diagnostic criteria will allow a thoughtful and
ystematic evaluation of patients potentially harboring the SQTS. The
se of a diagnostic scorecard will assist in bringing uniformity to the
iagnosis of this rare condition, as it has for other conditions, such as
rrhythmogenic right ventricular cardiomyopathy, for which a single
linical test or observation cannot define the disease. Certainly, this
pproach should be favored over personal opinion.
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